Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells

Published:2021-01-14 Issue:3 Volume:18 Page:1048-1060
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zavoiura Oleksandr¹^ORCID,Brunner Bodo¹,Casteels Peter²,Zimmermann Luciana¹,Ozog Matthias¹,Boutton Carlo²,Helms Mike W.¹,Wagenaar Timothy³,Adam Volker¹,Peterka Josefine⁴,Metz-Weidmann Christiane¹,Deschaght Pieter²,Scheidler Sabine¹,Jahn-Hofmann Kerstin¹

Affiliation:

1. Sanofi, Biologics Research, Industriepark Höchst, 65926 Frankfurt am Main, Germany

2. Ablynx, a Sanofi Company, Technologiepark 21, 9052 Zwijnaarde, Belgium

3. Sanofi, Research, 640 Memorial Drive, Cambridge, 02139 Massachusetts, United States

4. Sanofi, TIDES platform, Industriepark Höchst, 65926, Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c01001

Reference31 articles.

1. Orignal Papers.

2. The current state and future directions of RNAi-based therapeutics

3. Strategies, design, and chemistry in siRNA delivery systems

4. Coronavirus puts drug repurposing on the fast track

5. Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies;Life Sciences;2024-05

2. Targeted delivery of immune-stimulating bispecific RNA, inducing apoptosis and anti-tumor immunity in cancer cells;iScience;2024-03

3. The Impact of Activating Agents on Non‐Enzymatic Nucleic Acid Extension Reactions;ChemBioChem;2024-02-12

4. Systemic delivery of a splice-switching oligonucleotide heteroduplex corrects splicing in central nervous system and muscle in spinal muscular atrophy mice;2024-01-25

5. Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy;Cell Death & Disease;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3